Newsletters
Volume 2, Fiscal 2008, April 2008
The second quarter of fiscal 2008 proved to be a period of strong independent third-party validation of Pyng Medical Corp.’s considerable progress to date and near-term commercial potential evidenced by positive news media coverage, receipt of a prominent industry award and the Company’s first industry analyst report.
More…
Volume 1, Fiscal 2008, January 2008
For Pyng Medical Corp., the end of the calendar year was marked by another quarter of strong financial performance combined with significant technology innovation and enhancements to our market-leading intraosseous infusion technology.
More…
Volume 4, Fiscal 2007, October 2007
Financial Results
We have just finished a strong fourth quarter. Our full year unaudited results for fiscal 2007 covering the period 1 October 2006 to 30 September 2007 were very strong: revenue for the year was $4.8 million, an increase of 60% over the previous year. Gross margin was $3.3 million, 69% of revenue, despite the drop in the US dollar. We generated approximately $900,000 in EBITDA cash flow and projected net income of $400,000, equivalent to $0.04/share and well ahead of our guidance for this year.
More…
Volume 3, Fiscal 2007, Aug 2007
Financial Results
We have just released our strong third quarter unaudited results for fiscal 2007, covering the period from 1 October 2006 to 30 June 2007. Pyng achieved record sales of $ 1.36 million, a 38% increase over the previous year. Our year-to-date revenue is now $3.4 million, a 63% increase over our prior year. Our sales and gross margin continues to be strong resulting in net income for the first three quarters of $275 thousand or 8% of sales and 2.8 cents per share.
More…
Volume 2, Fiscal 2007, April 2007
Financial Results
We have just released our strong mid-year unaudited results for fiscal 2007, covering the period from October 1, 2006 to March 31, 2007. Pyng achieved record sales of $2.1 million, an 85% increase over the previous year. Our gross margin improved to 70.5% of sales, an increase of 3.5 percentage points over the prior year first half. We increased our operating expenditures by $302K, reflecting our increased commitment to marketing and product development; this is a decrease of 14 percentage points relative to sales. Due to our strong sales and improved gross margin and operating expense ratios, our income for the first half was $227K, 11% of revenue, 2.3 cents per share.
More…
Volume I, Fiscal 2007, January 2007
Financial Results
We have just released our strong year-end audited results for fiscal 2006, covering the period from October 1, 2005 to September 30, 2006. Pyng achieved record sales of $3 million, a 7% increase over the previous year, despite the downward pressure of unfavorable exchange rates. Our gross margin continues to be strong at 68% of sales, which places us amongst the highest margin companies in our industry. We increased our operating expenditures by $180K, reflecting our increased commitment to marketing and product advancement.
More…
Volume III, October 2006
Investor Relations
As reported in our Oct 16 news release, total sales for fiscal year 2006 were $3,088,448 (FY2005 $2,797,744), a 10% sales increase. Fourth quarter sales were $ 979,300 (FY2005 $840,328), an increase of 17%. Q4 and Q3 sales were stronger and showed a marked increased over the previous 2 quarters and the same periods last fiscal.
More…
